Haemonetics Corporation has acquired Vivasure Medical Limited. The transaction is expected to enhance Haemonetics' business strategy and operational performance by expanding its product portfolio and market reach. The company anticipates benefits arising from the integration of Vivasure Medical's technologies, although actual results may vary due to various risks and uncertainties, including regulatory outcomes and competitive pressures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haemonetics Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: NE59651) on January 09, 2026, and is solely responsible for the information contained therein.